Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Calabrò

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Eating and Weight Disorders : EWD|May 31, 2019
Psychopathological and psychiatric evaluation of patients affected by lipodystrophyPasquale Fabio Calabrò, Giovanni Ceccarini, Alba Calderone, et al.
Cancer|April 28, 2009
Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinomaFabio Calabrò, Vito Lorusso, Gerardo Rosati, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical CenterLetizia Biso, Marco Carli, Shivakumar Kolachalam, et al.
European Urology|April 3, 2012
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literatureFabio Calabrò, Peter Albers, Carsten Bokemeyer, et al.
Journal of Clinical Medicine|August 28, 2020
Impact of Clinical Response to Neoadjuvant Chemotherapy in the Era of Robot Assisted Radical Cystectomy: Results of a Single-Center ExperienceUmberto Anceschi, Aldo Brassetti, Gabriele Tuderti, et al.
Cancer|March 26, 2003
Can patient selection for bladder preservation be based on response to chemotherapy?Cora N Sternberg, Vito Pansadoro, Fabio Calabrò, et al.
Frontiers in Oncology|November 29, 2012
An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumorsEugenio Donato Di Paola, Silvia Alonso, Rosa Giuliani, et al.
BJU International|January 4, 2012
Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatmentAndrea Mancuso, Eugenio Donato Di Paola, Alvaro Leone, et al.
Cancer Immunology Research|April 28, 2018
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin PathwayIlaria Grazia Zizzari, Chiara Napoletano, Andrea Botticelli, et al.
Cancers|July 29, 2025
Metastatic Melanoma Prognosis Prediction Using a TC Radiomic-Based Machine Learning Model: A Preliminary StudyAntonino Guerrisi, Maria Teresa Maccallini, Italia Falcone, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Eating and Weight Disorders : EWD|May 31, 2019
Psychopathological and psychiatric evaluation of patients affected by lipodystrophyPasquale Fabio Calabrò, Giovanni Ceccarini, Alba Calderone, et al.
Cancer|April 28, 2009
Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinomaFabio Calabrò, Vito Lorusso, Gerardo Rosati, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical CenterLetizia Biso, Marco Carli, Shivakumar Kolachalam, et al.
European Urology|April 3, 2012
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literatureFabio Calabrò, Peter Albers, Carsten Bokemeyer, et al.
Journal of Clinical Medicine|August 28, 2020
Impact of Clinical Response to Neoadjuvant Chemotherapy in the Era of Robot Assisted Radical Cystectomy: Results of a Single-Center ExperienceUmberto Anceschi, Aldo Brassetti, Gabriele Tuderti, et al.
Cancer|March 26, 2003
Can patient selection for bladder preservation be based on response to chemotherapy?Cora N Sternberg, Vito Pansadoro, Fabio Calabrò, et al.
Frontiers in Oncology|November 29, 2012
An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumorsEugenio Donato Di Paola, Silvia Alonso, Rosa Giuliani, et al.
BJU International|January 4, 2012
Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatmentAndrea Mancuso, Eugenio Donato Di Paola, Alvaro Leone, et al.
Cancer Immunology Research|April 28, 2018
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin PathwayIlaria Grazia Zizzari, Chiara Napoletano, Andrea Botticelli, et al.
Cancers|July 29, 2025
Metastatic Melanoma Prognosis Prediction Using a TC Radiomic-Based Machine Learning Model: A Preliminary StudyAntonino Guerrisi, Maria Teresa Maccallini, Italia Falcone, et al.
Pageof 8